Sargent Investment Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.15M | Buy |
134,295
+36,000
| +37% | +$576K | 0.29% | 66 |
|
|
2025
Q1 | $1.51M | Sell |
98,295
-1,000
| -1% | -$15.4K | 0.24% | 74 |
|
|
2024
Q4 | $2.03M | Sell |
99,295
-10,005
| -9% | -$205K | 0.33% | 62 |
|
|
2024
Q3 | $1.97M | Sell |
109,300
-13,280
| -11% | -$239K | 0.35% | 58 |
|
|
2024
Q2 | $1.99M | Sell |
122,580
-2,000
| -2% | -$32.5K | 0.41% | 52 |
|
|
2024
Q1 | $1.76M | Sell |
124,580
-2,520
| -2% | -$35.6K | 0.39% | 56 |
|
|
2023
Q4 | $1.33M | Hold |
127,100
| – | – | 0.29% | 70 |
|
|
2023
Q3 | $1.3M | Sell |
127,100
-18,075
| -12% | -$184K | 0.31% | 67 |
|
|
2023
Q2 | $1.09M | Sell |
145,175
-169,500
| -54% | -$1.28M | 0.27% | 75 |
|
|
2023
Q1 | $2.87M | Buy |
314,675
+6,000
| +2% | +$54.7K | 0.76% | 34 |
|
|
2022
Q4 | $2.82M | Buy |
308,675
+22,000
| +8% | +$201K | 0.87% | 30 |
|
|
2022
Q3 | $2.48M | Buy |
286,675
+71,580
| +33% | +$620K | 0.77% | 35 |
|
|
2022
Q2 | $1.62M | Buy |
+215,095
| New | +$1.62M | 0.5% | 52 |
|
|
2022
Q1 | – | Sell |
-52,550
| Closed | -$421K | – | 195 |
|
|
2021
Q4 | $421K | Buy |
52,550
+50,000
| +1,961% | +$401K | 0.1% | 131 |
|
|
2021
Q3 | $25K | Hold |
2,550
| – | – | 0.01% | 187 |
|
|
2021
Q2 | $25K | Buy |
+2,550
| New | +$25K | 0.01% | 195 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 193 |
|